Your browser doesn't support javascript.
loading
A 1-heteroaryl-4-piperidinyl-methyl pyrrolidinone, BMY 21502, delays the decay of hippocampal synaptic potentiation in vitro.
Gribkoff, V K; Bauman, L A; VanderMaelen, C P.
Afiliação
  • Gribkoff VK; Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492.
Neuropharmacology ; 29(11): 1001-9, 1990 Nov.
Article em En | MEDLINE | ID: mdl-2087253
ABSTRACT
The effects of the substituted pyrrolidinone, BMY 21502, on the properties of cell membranes, synaptic transmission and synaptic plasticity, were assessed in area CA1 of hippocampal slices from the rat. Application of the compound to the bath had no consistent direct effects on parameters of the cell membrane or evoked synaptic potentials, at concentrations of less than 30 microM. In a blind experimental design, BMY 21502 at 1.0 and 10 microM, but not 25 microM, significantly delayed the decay of long-term potentiation in slices obtained from young animals; in slices obtained from very old rats (2.5-3.2 yr), 10 microM BMY 21502 significantly delayed decay of long-term potentiation. Therefore BMY 21502 was active in a physiological model that may predict of cognitive enhancement.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicotrópicos / Pirimidinas / Pirrolidinonas / Sinapses / Hipocampo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Neuropharmacology Ano de publicação: 1990 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicotrópicos / Pirimidinas / Pirrolidinonas / Sinapses / Hipocampo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Neuropharmacology Ano de publicação: 1990 Tipo de documento: Article